IL6 and congenital rubella syndrome: Recent preclinical studies showed that recipient’s monocytes can be transactivated via the CD40-CD40L pathway and responsible for the bulk of IL-1 and IL-6 production during CRS, excluding models based solely on the direct interplay between CAR T cells and tumor cells.